Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Badri N. Pandey, Amit Kumar, Prabha Tiwari & Kaushala P. Mishra. (2010) Radiobiological basis in management of accidental radiation exposure. International Journal of Radiation Biology 86:8, pages 613-635.
Read now
Read now
HH Chen, MC Luo, MZ Sun, YX Hu, YH Wang, MY Jin & WY Cheng. (2005) Decorporating efficacy of catecholaminocarboxylate chelating agents for thorium-234 and protective effects on associated radiation injury. International Journal of Radiation Biology 81:4, pages 309-318.
Read now
Read now
V. VOLF. (1996) Treatment with 3,4,3-LIHOPO of simulated wounds contaminated with plutonium and americium in rat. International Journal of Radiation Biology 70:1, pages 109-114.
Read now
Read now
V. VOLF. (1996) Chelation therapy by DFO-HOPO and 3,4,3-LIHOPO for injected Pu-238 and Am-241 in the rat: effect of dosage, time and mode of chelate administration. International Journal of Radiation Biology 70:6, pages 765-772.
Read now
Read now
F. Paquet, JL. Poncy, H. Metivier, G. Grillon, P. Fritsch, R. Burgada, T. Bailly, K.N. Raymond & P.W. Durbin. (1995) Efficacy of 3,4,3-LIHOPO for Enhancing the Excretion of Plutonium from Rat after Simulated Wound Contamination as a Tributyl-n-phosphate Complex. International Journal of Radiation Biology 68:6, pages 663-668.
Read now
Read now
G.N. Stradling, S.A. Gray, J.C. Moody, M.J. Pearce, I. Wilson, R. Burgada, T. Bailly, Y. Leroux, K.N. Raymond & P.W. Durbin. (1993) Comparative Efficacies of 3,4,3-LIHOPO and DTPA for Enhancing the Excretion of Plutonium and Americium from the Rat After Simulated Wound Contamination as Nitrates. International Journal of Radiation Biology 64:1, pages 133-140.
Read now
Read now
Articles from other publishers (17)
Olivier Grémy, Karine Devilliers & Laurent Miccoli. (2023) Chelation therapy with 3,4,3-Li(1,2-HOPO) after pulmonary exposure to plutonium in rats. Chemico-Biological Interactions 378, pages 110488.
Crossref
Crossref
Qiwen Sun, Xiaomei Wang, Cen Shi, Jingwen Guan, Lanhua Chen, Yumin Wang, Shuao Wang & Juan Diwu. (2022) Effective mitigation of gadolinium deposition using the bidentate hydroxypyridinone ligand Me-3,2-HOPO. Dalton Transactions 51:34, pages 13055-13060.
Crossref
Crossref
Anne Van der Meeren, Jaime F. Angulo, Sandra Bohand & Nina M. Griffiths. (2019) A quick and simple in vitro assay to predict bioavailability of actinides following accidental exposure. Toxicology in Vitro 58, pages 142-149.
Crossref
Crossref
A. Kirstin Sockwell & Modi Wetzler. (2018) Beyond Biological Chelation: Coordination of f‐Block Elements by Polyhydroxamate Ligands. Chemistry – A European Journal 25:10, pages 2380-2388.
Crossref
Crossref
Rebecca J. Abergel. 2016. Metal Chelation in Medicine. Metal Chelation in Medicine
183
212
.
Ole Andersen. 2016. Chelation Therapy in the Treatment of Metal Intoxication. Chelation Therapy in the Treatment of Metal Intoxication
253
284
.
Moses Q. Wilks, Marc D. Normandin, Hushan Yuan, Hoonsung Cho, Yanyan Guo, Fanny Herisson, Cenk Ayata, Dustin W. Wooten, Georges El Fakhri & Lee Josephson. (2015) Imaging PEG-Like Nanoprobes in Tumor, Transient Ischemia, and Inflammatory Disease Models. Bioconjugate Chemistry 26:6, pages 1061-1069.
Crossref
Crossref
Thomas E. Albrecht-Schmitt, Peter C. Burns & Sergey V. Krivovichev. 2011. The Chemistry of the Actinide and Transactinide Elements. The Chemistry of the Actinide and Transactinide Elements
3339
3440
.
Patricia W. Durbin. (2008) LAURISTON S. TAYLOR LECTURE: THE QUEST FOR THERAPEUTIC ACTINIDE CHELATORS. Health Physics 95:5, pages 465-492.
Crossref
Crossref
David R. Cassatt, Joseph M. Kaminski, Richard J. Hatchett, Andrea L. DiCarlo, Jessica M. Benjamin & Bert W. Maidment. (2008) Medical Countermeasures against Nuclear Threats: Radionuclide Decorporation Agents. Radiation Research 170:4, pages 540-548.
Crossref
Crossref
Anne E. V. Gorden, Jide Xu, Kenneth N. Raymond & Patricia Durbin. (2003) Rational Design of Sequestering Agents for Plutonium and Other Actinides. Chemical Reviews 103:11, pages 4207-4282.
Crossref
Crossref
Jide Xu, Donald W. Whisenhunt, Alan C. Veeck, Linda C. Uhlir & Kenneth N. Raymond. (2003)
Thorium(IV) Complexes of Bidentate Hydroxypyridinonates
1
. Inorganic Chemistry 42:8, pages 2665-2674.
Crossref
Crossref
Jide Xu, Emil Radkov, Marco Ziegler & Kenneth N. Raymond. (2000)
Plutonium(IV) Sequestration: Structural and Thermodynamic Evaluation of the Extraordinarily Stable Cerium(IV) Hydroxypyridinonate Complexes
1
. Inorganic Chemistry 39:18, pages 4156-4164.
Crossref
Crossref
Jide Xu & Kenneth N. Raymond. (1999)
Uranyl Sequestering Agents: Correlation of Properties and Efficacy with Structure for UO
2
2+
Complexes of Linear Tetradentate 1-Methyl-3-hydroxy-2(1
H
)-pyridinone Ligands
1
. Inorganic Chemistry 38:2, pages 308-315.
Crossref
Crossref
B Ramounet, S Matton, G Grillon & P Fritsch. (1998) Early biokinetics of actinides after intravenous administration of soluble forms of Pu(IV), Np(IV) and Np(V). Journal of Alloys and Compounds 271-273, pages 103-105.
Crossref
Crossref
G.N Stradling. (1998) Decorporation of actinides: a review of recent research. Journal of Alloys and Compounds 271-273, pages 72-77.
Crossref
Crossref
N.C. O'Boyle, G.P. Nicholson, T.J. Piper, D.M. Taylor, D.R. Williams & G. Williams. (1997) A review of plutonium(IV) selective ligands. Applied Radiation and Isotopes 48:2, pages 183-200.
Crossref
Crossref